204 related articles for article (PubMed ID: 31904768)
1. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
Qin J; Saraiya M; Martinez G; Sawaya GF
JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
[TBL] [Abstract][Full Text] [Related]
2. Use of the Papanicolaou test in women under 25 years of age in Southern Alberta.
Snodgrass R; Naugler C
J Obstet Gynaecol Can; 2014 Apr; 36(4):320-3. PubMed ID: 24798669
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Screening, Pelvic Examinations, and Contraceptive Use Among Adolescent and Young Adult Females.
Vinekar KS; Vahratian A; Hall KS; West BT; Caldwell A; Bell JD; Dalton VK
J Adolesc Health; 2015 Aug; 57(2):169-73. PubMed ID: 26026477
[TBL] [Abstract][Full Text] [Related]
4. Required examinations and tests before initiating contraception: Provider practices from a national cross-sectional survey.
Krashin JW; Zapata LB; Morgan IA; Tepper NK; Jatlaoui TC; Frederiksen BN; Whiteman MK; Curtis KM
Contraception; 2021 Apr; 103(4):232-238. PubMed ID: 33454373
[TBL] [Abstract][Full Text] [Related]
5. Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study.
Mignot S; Ringa V; Vigoureux S; Zins M; Panjo H; Saulnier PJ; Fritel X
BMC Cancer; 2019 Apr; 19(1):317. PubMed ID: 30952209
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and Factors Associated With Receiving a Pelvic Examination or Pap Testing Under the Age of 21 Years.
Mason RE; Sappenfield OR; Turyk ME; Caskey RN; Chor J
J Adolesc Health; 2020 Oct; 67(4):562-568. PubMed ID: 32430262
[TBL] [Abstract][Full Text] [Related]
7. Screening for Cervical Cancer and Sexually Transmitted Diseases Among HIV-Infected Women.
Frazier EL; Sutton MY; Tie Y; McNaghten AD; Blair JM; Skarbinski J
J Womens Health (Larchmt); 2016 Feb; 25(2):124-32. PubMed ID: 26447835
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening in the US-Mexico border region: a binational analysis.
Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
[TBL] [Abstract][Full Text] [Related]
9. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
10. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
[TBL] [Abstract][Full Text] [Related]
11. A population-based study of US women's preferred versus usual sources of reproductive health care.
Hall KS; Patton EW; Crissman HP; Zochowski MK; Dalton VK
Am J Obstet Gynecol; 2015 Sep; 213(3):352.e1-14. PubMed ID: 25935780
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening practices among women in Ghana: evidence from wave 2 of the WHO study on global AGEing and adult health.
Calys-Tagoe BNL; Aheto JMK; Mensah G; Biritwum RB; Yawson AE
BMC Womens Health; 2020 Mar; 20(1):49. PubMed ID: 32138737
[TBL] [Abstract][Full Text] [Related]
13. Missed connections: Unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections.
Bogler T; Farber A; Stall N; Wijayasinghe S; Slater M; Guiang C; Glazier RH
Can Fam Physician; 2015 Oct; 61(10):e459-66. PubMed ID: 26759845
[TBL] [Abstract][Full Text] [Related]
14. Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.
Setse R; Siberry GK; Moss WJ; Gravitt P; Wheeling T; Bohannon B; Dominguez K;
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):27-34. PubMed ID: 22088311
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening among women without a cervix.
Sirovich BE; Welch HG
JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
[TBL] [Abstract][Full Text] [Related]
16. Do new guidelines and technology make the routine pelvic examination obsolete?
Westhoff CL; Jones HE; Guiahi M
J Womens Health (Larchmt); 2011 Jan; 20(1):5-10. PubMed ID: 21194307
[TBL] [Abstract][Full Text] [Related]
17. Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy.
Teoh D; Isaksson Vogel R; Hultman G; Monu M; Downs L; Geller MA; Le C; Melton-Meaux G; Kulasingam S
Obstet Gynecol; 2017 Mar; 129(3):448-456. PubMed ID: 28178049
[TBL] [Abstract][Full Text] [Related]
18. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
Al Rifai R; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
20. Unintended Consequences: The Impact of Cervical Cancer Screening Guidelines on Rates of STI Screening in Primary Care.
Zur R; Casson M; Bellaire J; Yudin M
J Obstet Gynaecol Can; 2021 Mar; 43(3):344-351. PubMed ID: 33422408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
